Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/jfAYhMrCCowmupiZuV

December 7, 2007 News for medical technology professionals   Top Story    Bipartisan bill would require e-Rx for Medicare A bill that would provide incentives for physicians to e-prescribe for Medicare patients has bipartisan support in Congress as well as the backing of the White House. The bill would require Medicare scripts to be electronic by 2011, with one-time payments to doctors who e-prescribe beginning in 2008. Health Data Management (12/5), Government Health IT magazine (12/2007) White Paper - 21 CFR Part 820 & ISO 13485 - What's the Difference? The paper describes how the regulations relate and outlines cGMP regulations for manufacturers and importers, covering design, manufacturing, packaging, and servicing of medical devices. Download Now   Business & Market Trends    Former official sues Cleveland Clinic Jay Yadav, who ran the Cleveland Clinic's vascular intervention unit until he was fired last year over conflict-of-interest issues, has sued the clinic. He alleges defamation and discrimination, and claims financial conflicts of interest are "widespread and pervasive" at the hospital. The clinic denied the allegations in the lawsuit. The Wall Street Journal (tiered subscription model) (12/7) Wash. chiropractic group urges ban on unproven device The Washington State Chiropractic Association has asked members of the Chiropractic Quality Assurance Commission to ban EPFX, an unproven medical device designed to detect and treat diseases, in response to a Seattle Times report on the use of the machines. The commission is expected to issue its decision on the device, which is under FDA investigation, by February. The Seattle Times (12/7) Roche, ARK sign partnership over drug-monitoring products Roche Diagnostics and ARK Diagnostics signed a partnership agreement allowing Roche to market ARK's anti-HIV drug-monitoring products worldwide. The products are immunoassay reagents for specific classes of anti-HIV drugs that inhibit viral replication. American City Business Journals/Silicon Valley/ San Jose (12/6) Health IT groups unveil regulatory timeline The North Carolina Healthcare Information and Communications Alliance and the Workgroup for Electronic Data Interchange have launched their first regulatory timeline to help inform industry stakeholders about health IT initiatives. The timeline outlines the implementation of version 5010 of the HIPAA standard transactions and estimates completion by 2014. Health Data Management (12/6) Other News Integra donates $4M in neurosurgical medical devices to foundation The Times (Trenton, N.J.) (12/7) MedQuist cuts 200 jobs in restructuring move Health Data Management (12/6) Become more competitive, expand your business advantage and drive innovation through technology. Learn how to better respond to marketplace needs and deliver real business value. View our white papers and listen to our podcasts to learn how to accelerate delivery of new products, speed time-to-market and grow your business.   Science & Health  New endoscope shows promise for bile-duct disorders Doctors at a medical center in Spokane, Wash., hope Boston Scientific Corp.'s SpyGlass, a miniaturized endoscope used in detecting and treating bile-duct disorders, will cut down on the number of required surgical procedures. The device allows doctors access to the bile ducts and could be applied in the treatment of difficult bile stones and primary sclerosing cholangitis, a disease that causes scarring of the bile ducts. The Journal of Business (Spokane, Wash.) (12/6) Stem cell breakthrough treats sickle cell in mice U.S. scientists successfully treated mice with sickle cell anemia using induced pluripotent stem cells that behave like embryonic stem cells, which were converted from skin cells derived from the tail tips of each mouse. Researchers expressed optimism on the role of iPS cells in the treatment of diseases, but cautioned that gene-altered viruses used in the procedure should be replaced before conducting human testing since they have the potential to cause tumor development. The Washington Post (12/7) Stem cell bank seeks to add skin-cell-derived cell lines A stem cell bank established by the NIH in Madison, Wis., wants to house and distribute new cell lines derived from a technique that turns skin cells into embryonic stem cells. The bank could help maintain the efficient distribution of the cells to scientists and ensure the quality of the cell lines, the NIH Stem Cell Task Force leader said. International Herald Tribune/Associated Press (12/7) Study: Receptors linked to blood-vessel inflammation in diabetics A U.S. study found that increased expression of TLR2 and TLR4, two receptors in the innate immune system that are part of the pattern-recognition receptors, in people with Type 1 diabetes raises their risk of blood-vessel inflammation. Researchers said controlling diabetes might help lower risks of inflammation and cardiovascular diseases. Forbes/HealthDay News (12/6) Other News Longest-living recipient of artificial heart dies of organ failure Los Angeles Times (12/7) The Buzz(CORPORATE ANNOUNCEMENTS) How Is "Meta-Analysis" Changing Drug Safety? JUST RELEASED: Understanding The New Drug Safety Standards: The Emerging Science of Meta-Analysis. See what the experts are saying in this special report and Avandia case study from "The Pink Sheet". Find out more or call 800-332-2181. Interested in learning more about advertising in AdvaMed SmartBrief? Contact Meryl Harold at (202) 407-7828 or mharold@smartbrief.com.     Emerging Technologies  Japanese regulators OK Micrus Endovascular microcoil device The Ministry of Health, Labour and Welfare in Japan has granted San Jose, Calif.-based Micrus Endovascular Corp. approval to market its stretch-resistant microcoils used in treating cerebral aneurysms. The company intends to market the device immediately and also is aiming to get approval for its bioactive microcoils in Japan. American City Business Journals/Silicon Valley/San Jose (12/6)   AdvaMed News  AdvaMed-MTLI helps you prepare for the regulatory process in 2008 with two great courses Gear up for your company's 2008 business by joining the first AdvaMed-MTLI course of the year, Jan. 22 and 23 in Orlando! "Complaints, MDRs, Reports of Removals and Corrections and Recalls" will teach you how to navigate the regulatory process for medical device reporting, complaint handling and corrective actions. Sign up now. AdvaMed-MTLI is offering this course in conjunction with "Integrating Your Complaint Handling System with CAPA and Management Review," Jan. 23 and 24 in Orlando. Preview this agenda. Register for both courses and save up to $200! Now available! See AdvaMed-MTLI's schedule of courses Don't miss your turn to learn! See AdvaMed-MTLI's schedule of courses here. Learn more about AdvaMed -> About AdvaMed  |  Join  |  Courses  |  Events  |  Newsroom   SmartQuote  Apply yourself. Get all the education you can, but then, by God, do something. Don't just stand there, make it happen." --Lee Iacocca, industrialist     Subscriber Tools       Print friendly format | Web version | Search past news | Archive | Privacy policy Advertise Account Executive:  Meryl Harold (202) 407-7828 Download Media Kit Job Board:  Celia Rothschild (202) 470-1159   Read more at SmartBrief.com A powerful website for SmartBrief readers including: Industry Home Readers' Choice Search Archive Who's Hiring? Grab our News Widget Get this RSS Feed Publish your Press Release Download the SmartBrief Android app       Recent AdvaMed SmartBrief Issues: Thursday, December 06, 2007 Wednesday, December 05, 2007 Tuesday, December 04, 2007 Monday, December 03, 2007 Friday, November 30, 2007     Lead Editor:  Kathryn Doherty       Mailing Address: SmartBrief, Inc.®, 1100 H ST NW, Suite 1000, Washington, DC 20005     © 1999-2011 SmartBrief, Inc.® Legal Information